Understanding Dopamine Receptors for Better Medications

Structure and Function of Dopamine Receptors

NIH-funded research New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC · NIH-11120953

This work explores how dopamine receptors, which are targeted by current mental health medications, interact with other receptors to help create new treatments with fewer side effects.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11120953 on NIH RePORTER

What this research studies

We are looking closely at how dopamine D2 receptors, the main targets of all current antipsychotic drugs, connect with other receptors in the body. These connections, called complexes, might hold the key to developing new medications that work more precisely and cause fewer unwanted side effects. Our team is using advanced imaging techniques to watch individual receptor molecules in living cells, helping us understand their behavior in real-time. This detailed view will help us learn if these receptor complexes truly exist and how they function, paving the way for more targeted therapies.

Who could benefit from this research

Good fit: This foundational research is relevant to individuals living with mental health conditions currently treated with antipsychotic medications.

Not a fit: Patients not affected by conditions requiring antipsychotic medications would not directly benefit from this specific research.

Why it matters

Potential benefit: If successful, this research could lead to the development of new antipsychotic medications that are more effective and have significantly fewer side effects for patients.

How similar studies have performed: While the existence and physiological relevance of these receptor complexes are still debated, this project uses novel single-molecule imaging techniques rarely applied to these specific receptors in living mammalian cells.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.